Frequent incidence of lyme neuroborreliosis in children in the Czech Republic;Čast́y výskyt lymeské neuroboreliózy u dětí v České Republice

Ceska a Slovenska Neurologie a Neurochirurgie

Volumn 76, Issue 1, 2013, Pages 63-69

  Libá Vrabelová, Zuzana ^a   Kayserova J ^a   Komarek V ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Borrelia burgdorferi; Lyme neuroborreliosis; Peripheral facial nerve palsy

Indexed keywords

BACTERIAL DNA; BACTERIUM ANTIBODY;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; CYTOLOGY; CZECH REPUBLIC; ERYTHEMA; FACIAL NERVE PARALYSIS; HEADACHE; HUMAN; INCIDENCE; INFANT; LABORATORY TEST; LYME DISEASE; MAJOR CLINICAL STUDY; MENINGISM; NEUROLOGIC DISEASE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; TICK BITE; UNCONSCIOUSNESS;

EID: 84873448839     PISSN: 12107859     EISSN: 18024041     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rizzoli A, Hauffe HC, Carpi G, Vourc'h GI, Neteler M, Rosà R. Lyme neuroborreliosis in Europe. Eurosurveillance 2011; 16(27).
2. Křupka M, Raška M, Weigl E. Lymská borelióza - biologie, patogeneze, diagnostika a léčba. Dermatol Prax 2008; 2(5-6): 236-239.
3. Hulínská D, Kybicová K. Diagnostika lymeské borreliózy v Národní referenční laboratoři pro lymeskou borreliózu, SZÚ, 2008 [on-line]. Dostupné z: http://wwwszu.cz/tema/prevence/diagnostika-lymeske- borreliozy-v-nrl-lb.
4. Skowronek-Bala B, Wesolowska E, Gergont A, Kacinski M. Neuroboreliosis with motoric disturbations in the developmental age. Przegl Lek 2008; 65(11): 810-812.
5. Smith R, Takkinen J. Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Eurosurveillance 2006; 11(25).
6. Kříž B, Beneš Č. Lymeská borrelióza - epidemiologická data, SZÚ, 2010 [on-line]. Dostupné z: http://www.szu.cz/tema/prevence/lymeska-borrelioza- epidemiologicka-data-1.
7. Rupprecht TA. Neuroborreliosis: Pathogenesis, Symptoms, Diagnosis, and Treatment: Epidemiology [on-line]. Dostupné z: http://www.medscape.org/ viewarticle/738274-2.
8. López-Alberola RF. Neuroborreliosis and the pediatric population: a review. Rev Neurol 2006; 42 (Suppl 3): S91-S96. (Pubitemid 47426076)
9. Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol Med 2008; 14(3-4): 205-212. (Pubitemid 351481851)
10. Pachner AR Lyme neuroborreliosis In: Antel J et al (eds). Clinical neuroimmunology. 2nd ed. Oxford, USA: Oxford University Press 2005: 301-314.
11. Ramesh G, Borda JT, Dufour J, Kaushal D, Ramamoorthy R, Lackner AA et al. Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol 2008; 173(5): 1415-1427.
12. Dennis VA, Dixit S, O'Brien SM, Alvarez X, Pahar B, Philipp MT. Live Borrelia burgdorferi spirochetes elicit inflammatory mediators from human monocytes via Toll-like receptor signaling pathway. Infect Immun 2009; 77(3): 1238-1245.
13. Kigerl KA, Lai W, Rivest S, Hart RP, Satoskar AR, Popovich PG. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 2007; 102(1): 37-50. (Pubitemid 46906264)
14. Henningsson AJ, Tjernberg I, Malmvall BE, Forsberg P, Ernerudh J. Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study. J Neuroinflammation 2011; 8: 36
15. Janeway CA et al. T-cell mediated immunity. In: Janeway CA et al (eds). Immunology. 6th ed. New York: Garland Science publishing 2007: 319-362.
16. Hinojosa AE, Garcia-Bueno B, Leza JC, Madrigal JL. CCL2/MCP-1 modulation of microglial activation and proliferation. J Neuroinflammation 2011; 8: 77.
17. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA jr et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999; 398(6729): 718-723.
18. Hildenbrand P, Craven DE, Jones R, Nemeskal P. Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis AJNR Am J Neuroradiol 2009; 30(6): 1079-1087.
19. Vrethem M, Widhe M, Ernerudh J, Garpmo U, Forsberg P. Clinical, diagnostic and immunological characteristics of patients with possible neuroborreliosis without intrathecal Ig-synthesis against Borrelia antigen in the cerebrospinal fluid. Neurol Int 2011; 3(1): e2.
20. Widhe M, Jarefors S, Ekerfelt C, Vrethem M, Bergstrom S, Forsberg P et al. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis 2004; 189(10): 1881-1891. (Pubitemid 38657224)
21. Herrath MG, Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003; 3(3): 223-232. (Pubitemid 37323207)
22. Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004; 4(11): 841-55 (Pubitemid 39490760)
23. Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17(1): 8-16
24. European Concerned Action on Lyme Borreliosis; Treatment of Lyme borreliosis in Europe [on-line]. Dostupné z: www.eucalb com.
25. Strieker RB. Counterpoint: Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease. Clin Infect Dis 2007; 45(2): 149-157.
26. Gurčík L. Súčasné trendy v diagnostike a liečbě neuroboreliózy. Neurol Prax 2009; 10(3): 170-176.